Use access key #2 to skip to page content.
$76.95 1.12 (1.48%)
9/5/2008 2:44 PM

Cephalon, Inc. (CEPH)

CAPS Rating:
*****

An international biopharmaceutical company dedicated to the discovery, development and marketing of innovative products to treat human diseases. Currently its four core therapeutic areas are central nervous system disorders, pain, cancer and addiction.

View Ticker Page (CEPH)

Results 1 - 10 of 19 :   12

Recs

5

Avatar NetscribeBiotech (79.21) Submitted: 2/22/07 2:17 AM : Outperform Start Price: $73.00 CEPH Score: 20.15

Cephalon, Inc. is a biopharmaceutical company that is involved in discovery, development and marketing of products in four primary therapeutic areas: central nervous system disorders (CNS), pain, cancer and addiction. The company’s products include P...

Report this Post Replies: 1 | Reply | Permalink

Recs

2

Avatar genxer36 (64.80) Submitted: 5/29/07 3:15 AM : Outperform Start Price: $80.01 CEPH Score: 14.24

Their mission is to discover and develop innovative medicine for improving human health, Cephalon specializes in medications to treat and manage neurological diseases, sleep disorders, cancer, pain and addiction.

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar FreethinkerKW (66.67) Submitted: 9/18/06 6:52 AM : Outperform Start Price: $55.50 CEPH Score: 44.05

Excellent read on how Cephalon listens to how doctors are using Provogil and then has them collaborate in studies. Also, the company's CEO seems lasar focused on enhancing the pipeline through research.

This is one to keep in the files for Cephalon:...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar bouhassi (75.56) Submitted: 6/10/07 11:12 PM : Outperform Start Price: $82.37 CEPH Score: 10.96

I had the stock or 5 years will growth slowly

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar tjblacksr (< 20) Submitted: 1/04/07 11:09 AM : Outperform Start Price: $69.55 CEPH Score: 22.41

Great stock, have held a long position since 1999 and traded actively over time period with very positive results.
Great Management and product/pipeline strategies. FDA look at Nuvigil could create relook at Sparlon which should have been approved, a...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar boysheagain (< 20) Submitted: 5/04/07 10:35 AM : Outperform Start Price: $79.87 CEPH Score: 13.83

Because of the products it has to offer and the management it provides.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar davidr825 (< 20) Submitted: 8/24/06 12:55 PM : Outperform Start Price: $58.79 CEPH Score: 35.11

The track record for this company speaks for itself

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar ramram50 (25.29) Submitted: 4/14/08 12:33 PM : Outperform Start Price: $63.20 CEPH Score: 28.27

CHEAP AND TAKEOVER CANDIDATE

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar AcubanFOOL (76.47) Submitted: 12/10/07 11:53 AM : Outperform Start Price: $78.64 CEPH Score: 15.82

86/98 -71.5

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar SierraBlue (66.93) Submitted: 7/21/08 12:00 PM : Outperform Start Price: $73.80 CEPH Score: 5.28

Barchart Scan - technical indicators; Drug Manufacturers

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners